GCNH Logo

Search Current Legislation

SB256-FN
  
Bill Details
Title: (New Title) establishing safety and care requirements for clinician-administered drugs.
LSR Number: 25-1003
General Status: HOUSE
House:
Committee: Commerce and Consumer Affairs
Due Out: 5/7/2026
Status: INTERIM STUDY
Senate:
Committee: Health and Human Services
Floor Date: 1/7/2026
Status: PASSED/ADOPTED WITH AMENDMENT
Documents
Bill Docket
Body
Description
S
Introduced 01/09/2025 and Referred to Health and Human Services; SJ 3
S
Hearing: 02/12/2025, Room 101, LOB, 09:15 am; SC 9
S
Committee Report: Rereferred to Committee, 03/06/2025; Vote 5-0; CC; SC 11
S
Rereferred to Committee, MA, VV; 03/06/2025; SJ 6
S
Committee Report: Ought to Pass with Amendment #2025-3029s, 01/07/2026; Vote 5-0; CC; SC 46
S
Committee Amendment #2025-3029s, AA, VV; 01/07/2026; SJ 1
S
Ought to Pass with Amendment #2025-3029s, MA, VV; OT3rdg; 01/07/2026; SJ 1
H
Introduced (in recess of) 02/19/2026 and referred to Health, Human Services and Elderly Affairs HJ 5 P. 124
H
Vacated and Referred to Commerce and Consumer Affairs (Rep. Kofalt): MA VV (in recess of) 02/19/2026 HJ 5 P. 127
H
Public Hearing: 04/07/2026 02:15 pm GP 159
H
Subcommittee Work Session: 04/08/2026 10:00 am GP 229
H
Subcommittee Work Session: 04/22/2026 10:00 am GP 229
H
Executive Session: 04/29/2026 10:00 am GP 229
H
Committee Report: Refer for Interim Study 04/29/2026 (Vote 15-0; CC) HC 19 P. 6
H
Refer for Interim Study: MA VV 05/14/2026 HJ 13